Efficient capital deployment in Israel and Singapore designed to support scale-up in key markets Aleph Farms, the first company to grow cultivated steaks directly from non-modified cow cells, today announced that it had acquired a manufacturing facility in Modi’in, Israel, and certain related assets from biotechnology company VBL Therapeutics (Nasdaq: VBLT). In addition, Aleph Farms has signed a Memorandum of Understanding (MOU) with ESCO Aster, a vertically-integrated contract manufacturing … [Read more...] about Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership
Ingredients
Kerry and c-LEcta enter agreement to market DENARASE® products
28 February 2023: Kerry, a world leader in taste and nutrition, and c-LEcta, a leading biotechnology company in enzyme engineering and bioprocess development, have announced a new partnership to jointly market DENARASE® products. The DENARASE® product family was launched in 2012 and applied in hundreds of clinical and commercial production processes for gene/cell therapies and vaccines. Combining Kerry and c-LEcta’s expertise in the biopharma and pharmaceutical sectors, the partnership will … [Read more...] about Kerry and c-LEcta enter agreement to market DENARASE® products
FreshToHome closes $104MM in Series D funding
FreshToHome, the world's largest fully integrated online consumer brand for preservative and antibiotic-residue free fresh fish and meat, has closed $104 million in Series D funding with Amazon Smbhav Venture Fund leading the round. Existing investors in FreshToHome, including Iron Pillar, Investcorp, Investment Corporation of Dubai (the principal investment arm of the Government of Dubai), Ascent Capital, and others, have also participated in this round. New investors joining this round include … [Read more...] about FreshToHome closes $104MM in Series D funding